Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.

Ever since I became a contact lens wearer many years ago, chronic dry eyes and I have become fast and familiar friends. That ...